Login / Signup

Accidental intoxications in toddlers: lack of cross-reactivity of vilazodone and its urinary metabolite M17 with drug of abuse screening immunoassays.

Christina D Martinez-BrokawJoshua B RadkeJoshua G PierceAlexandra EhlersSean EkinsKelly E WoodJon MaakestadJacqueline A RymerKenichi TamamaMatthew David Krasowski
Published in: BMC clinical pathology (2019)
While the vilazodone metabolite M17 has weak 2D structural similarity to amphetamines and tricyclic antidepressants, the current study did not demonstrate any experimental cross-reactivity with two different urine amphetamines immunoassays and a serum tricyclic antidepressant immunoassay. Vilazodone ingestions in young children present a diagnostic challenge in their similarity to amphetamine ingestions and the lack of routine laboratory tests for vilazodone. Further work is needed to understand the metabolic profile for vilazodone in children versus adults.
Keyphrases
  • major depressive disorder
  • young adults
  • sensitive detection